Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1993-05-10
1994-05-03
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514220, 5142332, 514250, 540496, 540497, 540556, 544 33, 544115, 544346, C07D49518, C07D51318, A61K 3154, A61K 31495
Patent
active
053088425
ABSTRACT:
Conformationally constrained tricyclic derivatives of the thienodiazocine and thienothiadiazocine classes of compounds and ring homologs thereof are topically effective carbonic anhydrase inhibitors useful in the treatment of ocular hypertension and glaucoma associated therewith. The compounds are of general structure ##STR1##
REFERENCES:
patent: 4797413 (1989-01-01), Baldwin et al.
Baldwin John J.
Ponticello Gerald S.
Ayler Sylvia A.
Daniel Mark R.
DiPrima Joseph F.
Ford John M.
Merck & Co. , Inc.
LandOfFree
Tricyclic derivatives of the thienodiazocine and thienothiadiazo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic derivatives of the thienodiazocine and thienothiadiazo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic derivatives of the thienodiazocine and thienothiadiazo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2115222